ArticleExperimental and therapeutic medicine2018
Assessment of levels of D-dimer and interferon-γ in pediatric patients with
Article in Experimental and therapeutic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.
- Value of D-dimer in predicting various clinical outcomes following community-acquired pneumonia: A network meta-analysis.PloS one · 2022Pooled it
- Analysis of the Nursing Effect of Respiratory Critical Illness Based on Refined Nursing Management.Computational and mathematical methods in medicine · 2022Trial
- Application of Clinical Indicators in the Early Prediction of RefractoryClinical pediatrics · 2026Article
- Independent risk factors for refractory mycoplasma pneumoniae pneumonia in children: a multivariate analysis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
- Epidemiology, clinical characteristics, and risk factors of plastic bronchitis caused by severe Mycoplasma pneumoniae pneumonia in children: a retrospective study from Suzhou, China.Frontiers in pediatrics · 2026Article
- Clinical profile and risk factors for respiratory failure in children withBiomolecules & biomedicine · 2025Article
- Risk analysis of poor prognosis and follow-up observation of children withFrontiers in pediatrics · 2025Article
- Case Report: RefractoryFrontiers in pediatrics · 2025Article
- New-generation tetracyclines for severe macrolide-resistant Mycoplasma pneumoniae pneumonia in children: a retrospective analysis.BMC infectious diseases · 2024Article
- Clinical characteristics and risk factors of pulmonary embolism with Mycoplasma pneumoniae pneumonia in children.Scientific reports · 2024Article
- Comparative observation between Roxithromycin and Azithromycin sequential therapy in the treatment of Mycoplasma pneumoniae Pneumonia in Children.Pakistan journal of medical sciences · 2024Article
- Epidemiological characteristics and early predict model of children Mycoplasma Pneumoniae Pneumonia outbreaks after the COVID-19 in Shandong.Scientific reports · 2024Article
- [Value of calprotectin S100 A8/A9 in predicting the severity ofZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024Article
- Clinical characteristics and predictive indictors of macrolide-unresponsiveFrontiers in pediatrics · 2024Article
- Clinical value of monitoring cytokine levels for assessing the severity of mycoplasma pneumoniae pneumonia in children.American journal of translational research · 2024Article
- [Construction of a predictive model for performing bronchoalveolar lavage in children withZhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023Article
- Predictive value of chemokines (CCL 2) in bronchoalveolar lavage fluid for refractory mycoplasma pneumonia in children.Italian journal of pediatrics · 2023Article
- Metabolism Characteristics ofAllergy, asthma & immunology research · 2022Article
- Development of a Nomogram for Predicting RefractoryFrontiers in pediatrics · 2022Article
- Clinical features and risk factors analysis of bronchitis obliterans due to refractory Mycoplasma pneumoniae pneumonia in children: a nomogram prediction model.BMC infectious diseases · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Levels of D-dimer and interferon-γ (INF-γ) in pediatric patients with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.